in

Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson’s disease

Subcutaneous infusion of levodopa-carbidopa beneficial for parkinson disease

Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet Neurology.


Posted by Editor

Picky Consumers Jilting Big Brands Are Unilever India’s New Risk

Picky Consumers Jilting Big Brands Are Unilever India’s New Risk

My sex pest colleague is giving me the creeps

My sex pest colleague is giving me the creeps